Predictive Oncology Inc.
NASDAQ:POAI
1.19 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.78 | 1.505 | 1.421 | 1.252 | 1.412 | 1.412 | 0.655 | 0.456 | 0.654 | 0.952 | 0.468 | 0.189 | 0.097 | 0 | 0.016 | 0 |
| Cost of Revenue
| 0.635 | 0.505 | 0.487 | 0.447 | 0.532 | 0.416 | 0.148 | 0.182 | 0.304 | 0.385 | 0.19 | 0.129 | 0.056 | 0 | 0.007 | 0 |
| Gross Profit
| 1.145 | 1 | 0.934 | 0.805 | 0.88 | 0.996 | 0.507 | 0.275 | 0.35 | 0.566 | 0.278 | 0.06 | 0.041 | 0 | 0.009 | 0 |
| Gross Profit Ratio
| 0.643 | 0.664 | 0.657 | 0.643 | 0.623 | 0.705 | 0.774 | 0.602 | 0.535 | 0.595 | 0.595 | 0.319 | 0.42 | 0.514 | 0.555 | 0 |
| Reseach & Development Expenses
| 0.188 | 0.32 | 0.316 | 2.352 | 2.96 | 1.861 | 0.289 | 0.406 | 0.261 | 0.394 | 0.235 | 0.015 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 9.428 | 11.111 | 10.932 | 10.352 | 9.781 | 4.627 | 7.249 | 5.175 | 4.246 | 5.855 | 8.627 | 7.047 | 3.913 | 1.874 | 1.598 | 1.316 |
| Selling & Marketing Expenses
| 1.511 | 1.359 | 0.775 | 0.585 | 1.913 | 2.369 | 1.004 | 0.468 | 0.504 | 1.178 | 0.579 | 0.173 | 0.233 | 0.2 | 0.407 | 0.036 |
| SG&A
| 10.939 | 12.47 | 11.707 | 10.937 | 11.694 | 6.996 | 8.253 | 5.643 | 4.75 | 7.034 | 9.206 | 7.22 | 4.146 | 2.074 | 2.005 | 1.352 |
| Other Expenses
| 0 | 3.798 | 2.699 | -1.584 | -2.471 | 0.068 | 0 | 1.158 | 0 | 0 | 0 | 0 | 0 | -0.868 | 0.447 | 0 |
| Operating Expenses
| 15.129 | 16.268 | 14.405 | 13.289 | 14.654 | 8.857 | 8.253 | 6.801 | 4.75 | 7.034 | 9.206 | 7.22 | 4.146 | 1.206 | 2.452 | 1.673 |
| Operating Income
| -13.921 | -15.268 | -13.472 | -0.666 | -13.774 | -7.861 | -7.747 | -6.526 | -4.4 | -6.467 | -8.927 | -7.16 | -4.105 | -1.206 | -2.444 | -1.673 |
| Operating Income Ratio
| -7.821 | -10.142 | -9.482 | -0.532 | -9.758 | -5.569 | -11.83 | -14.296 | -6.724 | -6.797 | -19.071 | -37.928 | -42.483 | -4,186.167 | -155.281 | 0 |
| Total Other Income Expenses Net
| -0.063 | -10.47 | -6.847 | -13.401 | -5.616 | -2.225 | 0.051 | -0 | -0.391 | -0.366 | -0.62 | -0.262 | -0.381 | -0.147 | -0.449 | -0.089 |
| Income Before Tax
| -13.984 | -25.738 | -20.319 | -25.884 | -19.391 | -10.086 | -7.747 | -6.526 | -4.791 | -6.834 | -9.406 | -7.422 | -4.487 | -1.353 | -1.763 | 0 |
| Income Before Tax Ratio
| -7.856 | -17.096 | -14.302 | -20.67 | -13.737 | -7.145 | -11.83 | -14.296 | -7.321 | -7.181 | -20.094 | -39.318 | -46.43 | -4,696.906 | -112.005 | 0 |
| Income Tax Expense
| 0 | 10.47 | -0.662 | 11.817 | 8.165 | -2.225 | 0.051 | 0 | 0 | 0.378 | 0.637 | 0.259 | 0.23 | 0 | 0.449 | 0.089 |
| Net Income
| -13.984 | -36.208 | -19.657 | -37.702 | -27.556 | -10.086 | -7.747 | -6.526 | -4.791 | -6.834 | -9.406 | -7.422 | -4.487 | -1.353 | -2.892 | -1.763 |
| Net Income Ratio
| -7.856 | -24.051 | -13.836 | -30.107 | -19.522 | -7.145 | -11.83 | -14.296 | -7.321 | -7.181 | -20.094 | -39.318 | -46.43 | -4,696.906 | -183.785 | 0 |
| EPS
| -3.48 | -9.92 | -7.16 | -63.1 | -192.02 | -157.4 | -243.5 | -462.31 | -4,601.85 | -11,057.55 | -16,051.71 | -26,794.78 | -52,786.81 | -36,559.7 | -96,407.67 | -65,282.52 |
| EPS Diluted
| -3.48 | -9.92 | -7.16 | -63.1 | -192.02 | -157.4 | -243.5 | -462.31 | -4,601.85 | -11,057.55 | -16,051.71 | -26,794.78 | -52,786.81 | -36,559.7 | -96,407.67 | -65,282.52 |
| EBITDA
| -13.182 | -13.955 | -12.131 | -11.459 | -12.413 | -7.714 | -5.982 | -6.444 | -4.321 | -6.393 | -8.762 | -7.162 | -4.253 | -1.203 | -2.81 | -1.673 |
| EBITDA Ratio
| -7.405 | -2.195 | -4.702 | 0.286 | -3.474 | -5.464 | -11.721 | -14.115 | -6.604 | -6.73 | -18.753 | -37.922 | -42.45 | -4,177.733 | -131.599 | 0 |